Presentation TCT 2024 TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis Presenter: Daniel Mitchell October 30, 2024
Presentation TCT 2024 TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades Presenter: Zaid Abdulelah October 30, 2024
Presentation TCT 2024 TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease Presenter: Junaid Mir October 30, 2024
Presentation TCT 2024 Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED) Presenter: Mark Dweck October 30, 2024
Presentation TCT 2024 COUNTERPOINT: The Surgical Standard Will Predominate! Presenter: Michael Bowdish October 30, 2024
Presentation TCT 2024 Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed? Presenter: Yousif Ahmad October 30, 2024
Presentation TCT 2024 TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis Presenter: Joshua Zuniga October 30, 2024
Presentation TCT 2024 CONTROVERSY: Device Selection and Sizing for TAVR in BAVD Presenter: Didier Tchetche October 30, 2024
Presentation TCT 2024 TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life Presenter: Dirk Jan van Ginkel October 29, 2024
Presentation TCT 2024 TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes Presenter: Gijs Broeze October 29, 2024
Presentation TCT 2024 TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021 Presenter: Vidit Majmundar October 29, 2024
Presentation TCT 2024 TCT 640: Temporal Trends in Calcified Aortic Valve Disease-related Mortality in Canada Over the Past 30 Years Presenter: Zaid Abdulelah October 29, 2024
Presentation TCT 2024 TCT 1593: Sitosterolemia: A Extremely Rare Cause of Premature Coronary Artery Disease and Aortic Stenosis in the Young Presenter: Mohammed Ebrahim October 29, 2024
Presentation TCT 2024 TCT 829: Safety of Ruling Out Coronary Artery Disease by Computed Tomography Angiography Before Transcatheter Aortic Valve Replacement Presenter: Asa Phichaphop October 29, 2024
Presentation TCT 2024 TCT 828: Natural History of Coronary Artery Disease After Transcatheter Aortic Valve Implantation Presenter: Kalyan Chitturi October 29, 2024
Presentation TCT 2024 TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes Presenter: M. Abubakar Shakir October 29, 2024
Presentation TCT 2024 TCT 905: Impact of Vessel Anatomic Complexity and Technical Failure in Patients With Severe Peripheral Artery Disease Undergoing TAVI Presenter: Enrico Romagnoli October 29, 2024
Presentation TCT 2024 TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry Presenter: Yasser Sammour October 29, 2024
Presentation TCT 2024 TCT 830: Feasibility and Utility of Anatomical and Physiological Evaluation of Coronary Disease With Cardiac CT in Severe Aortic Stenosis (FUTURE-AS Registry) Presenter: Abdul Rahman Ihdayhid October 29, 2024